未知股票 BCLI 深 滬
已收盤
--
0.000
NaN.00%
華盛通- 最 高--
- 今 開--
- 成交量 --
- 最 低 --
- 昨 收 --
- 總市值 0
- 52周最高 --
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 --
- 委 比 0.00%
- 總股本 1103.48万
- 歷史最高 --
- 量 比 0
- 振 幅 NaN.00%
- 歷史最低 --
- 每 手 1
- 風險率 1.34%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多BCL Industries Links Share Volume Surge to Government E85 Fuel Programme
BCL Industries Ltd ( ($IN:BCLIND) ) has issued an announcement. BCL Industries ...
06-09 13:54
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts As Board Director
BrainStorm Cell Therapeutics Inc. (OTCQB:BCLI), a leading developer of autologous stem cell therapies for neurodegenerative diseases, today announced that Peter J. Pitts has been appointed to the Company's Board of
05-28 19:49
Brainstorm Cell Q1 EPS $(0.19) Beats $(0.36) Estimate
Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.36) by 47.22 percent. This is a 57.78 percent increase over losses of $(0.45) per share from the
05-16 04:12
Brainstorm Cell Q4 EPS $(0.20) Beats $(0.37) Estimate
Brainstorm Cell (OTC:BCLI) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.37) by 45.95 percent. This is a 60.78 percent increase over losses of $(0.51) per share from the
04-01 06:49
Brainstorm Cell secures $1M strategic financing
Brainstorm Cell Therapeutics (BCLI) has entered into a definitive agreement for a strategic private placement of $1M. The common stock was priced at $0.60 per share, representing a significant premium...
02-20 20:18
BRIEF-Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
BRIEF-Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market Feb 20 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.PK : BRAINSTORM CELL THERAPEUTICS ANNOUNCES $1 MILLION STRATEGIC FINANCING AT PREMIUM TO MARKET Source text: ID:nPnrPyRQa Further company coverage
02-20 19:10
Brainstorm Cell Therapeutics Secures New Convertible Debt Financing
Brainstorm Cell Therapeutics ( ($BCLI) ) has provided an announcement. On Decem...
01-10 06:06
BRIEF-Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Aug 14 (Reuters) - Brainstorm Cell Therapeutics Inc BCLI.PK: BRAINSTORM CELL THERAPEUTICS ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nPn47fLT8a Furth...
2025-08-14 20:07
Brainstorm Cell Therapeutics Inc <BCLI.PK> expected to post a loss of 37 cents a share - Earnings Preview
Brainstorm Cell Therapeutics Inc BCLI.PK is expected to show no change in quarterly revenue when it reports results on August 14 for the period ending June 30 2025 LSEG's mean analyst estimate for Br...
2025-08-09 01:48
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notice from Nasdaq effective July 18, 2025.
BrainStorm Cell Therapeutics is trading lower after receiving a delisting notic...
2025-07-18 04:42
